STOCK TITAN

Evolent Health: Cadian reports approximately 0.5% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Evolent Health, Inc. (EVH) is the issuer whose Class A shares are covered by an amended Schedule 13G: Cadian Capital Management, LP, its general partner Cadian Capital Management GP, LLC, and Eric Bannasch, the GP’s sole managing member, each may have been deemed to beneficially own 509,464 shares as of September 30, 2026. The shares were directly held by Cadian Master Fund L.P. and Cadian Opportunities Master Fund LP. Cadian Capital Management, LP exercises exclusive voting and investment power under investment management agreements. Each reporting person reported shared voting and dispositive power over 509,464 shares and zero sole power. The reported position was approximately 0.5% of the class, based on 113,059,335 shares outstanding as of August 1, 2026.

Beneficially owned shares 509,464 shares Each reporting person may have been deemed to beneficially own this amount as of September 30, 2026; the shares were held by two advisory clients.
Class ownership Approximately 0.5% Each reporting person’s reported beneficial ownership as of September 30, 2026.
Class A shares outstanding 113,059,335 shares Outstanding as of August 1, 2026, as disclosed in Evolent Health’s Form 10-Q.
Sole voting and dispositive power 0 shares Each reporting person’s reported power as of September 30, 2026.
beneficially owned technical
"may have been deemed to have beneficially owned 509,464 shares"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
shared voting power technical
"Shared Voting Power 509,464.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power technical
"Shared Dispositive Power 509,464.00"
Investment Management Agreements technical
"Pursuant to Investment Management Agreements between the Advisory Clients and the Adviser"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many EVH shares did Cadian report beneficially owning?

Each reporting person may have been deemed to beneficially own 509,464 shares of Evolent Health Class A Common Stock as of September 30, 2026. The shares were directly held by Cadian Master Fund L.P. and Cadian Opportunities Master Fund LP.

What voting power did the EVH ownership report disclose?

Each reporting person reported shared voting and dispositive power over 509,464 shares, with zero sole voting or dispositive power, as of September 30, 2026. Cadian Capital Management, LP exercises exclusive voting and investment power over securities held directly by the two advisory clients under investment management agreements.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





30050B101

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Cadian Capital Management, LP
Signature:/s/ Eric Bannasch
Name/Title:Eric Bannasch/Managing Member, Cadian Capital Management GP, LLC, its General Partner
Date:11/16/2026
Cadian Capital Management GP, LLC
Signature:/s/ Eric Bannasch
Name/Title:Eric Bannasch/Managing Member
Date:11/16/2026
Eric Bannasch
Signature:/s/ Eric Bannasch
Name/Title:Eric Bannasch/Self
Date:11/16/2026

Keep reading